安徽医学
安徽醫學
안휘의학
ANHUI MEDICAL JOURNAL
2014年
2期
186-188
,共3页
宛新安%周勤%韦永明%管睿%胡琴%丁海波%袁乐
宛新安%週勤%韋永明%管睿%鬍琴%丁海波%袁樂
완신안%주근%위영명%관예%호금%정해파%원악
胃癌%肝转移瘤%化疗栓塞
胃癌%肝轉移瘤%化療栓塞
위암%간전이류%화료전새
Gastric cancer%Liver metastasis%Chemoembolization
目的:探讨动脉化疗栓塞联合静脉化疗在胃癌肝转移中的治疗效果。方法将60例胃癌肝转移患者,随机分成动脉化疗栓塞联合静脉化疗组(试验组)和单纯化疗组(对照组),比较两组近期疗效和生活质量改善情况。结果试验组有效率为73.3%,生活质量改善率73.3%,对照组有效率为43.3%,生活质量改善率43.3%,差异均有统计学意义(P<0.05)。试验组内分层分析,富血供者疗效更佳。两组毒副反应均可以耐受。结论动脉化疗栓塞联合静脉化疗是胃癌肝转移的有效方法,尤其是在富血供的胃癌肝转移患者。
目的:探討動脈化療栓塞聯閤靜脈化療在胃癌肝轉移中的治療效果。方法將60例胃癌肝轉移患者,隨機分成動脈化療栓塞聯閤靜脈化療組(試驗組)和單純化療組(對照組),比較兩組近期療效和生活質量改善情況。結果試驗組有效率為73.3%,生活質量改善率73.3%,對照組有效率為43.3%,生活質量改善率43.3%,差異均有統計學意義(P<0.05)。試驗組內分層分析,富血供者療效更佳。兩組毒副反應均可以耐受。結論動脈化療栓塞聯閤靜脈化療是胃癌肝轉移的有效方法,尤其是在富血供的胃癌肝轉移患者。
목적:탐토동맥화료전새연합정맥화료재위암간전이중적치료효과。방법장60례위암간전이환자,수궤분성동맥화료전새연합정맥화료조(시험조)화단순화료조(대조조),비교량조근기료효화생활질량개선정황。결과시험조유효솔위73.3%,생활질량개선솔73.3%,대조조유효솔위43.3%,생활질량개선솔43.3%,차이균유통계학의의(P<0.05)。시험조내분층분석,부혈공자료효경가。량조독부반응균가이내수。결론동맥화료전새연합정맥화료시위암간전이적유효방법,우기시재부혈공적위암간전이환자。
Objective To Investigate the effect of liver metastasis from gastric cancer treated by the combination of transcatheter ar-terial chemoembolization and intravenous chemotherapy.Methods Totally 60 patients were divided into two group randomly.Experimental group was treated with transcatheter arterial chemoembolization combined with intravenous chemotherapy,and control group was treated with only intravenous chemotherapy.Therapeutic efficacy and quality of life of two groups were compared.Results The total effective rate and quality of life of experimental group(73.3%)were higher than those of the control group(43.3%),and there were significant differences(P<0.05).Especially,hypervascular cases got better efficacy.Conclusion Transcatheter arterial chemoembolization combined with intraveno-uschemotherapy is effective in the treatment of liver metastasis from gastric cancer.The therapeutic efficacy of hypervascular metastatic tumor is better than that of hypovascular metastatic tumor.